In summary, this study showed that KLF7 promoted the development of HCC through Trp metabolism and identified the involvement of new axis of KLF7/SLC1A5 in HCC, which may represent therapeutic markers for HCC. Here, SLC1A5 is linked to hepatocellular carcinoma.